Atrás
Rango del Día
$13.11
$14.13
Rango de 52 Semanas
$2.86
$36.26
Volumen
1,390,322
Promedio 50D / 200D
$23.15
/
$14.30
Cierre Anterior
$13.97
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -7.5 | 0.3 |
| P/B | 2.5 | 2.9 |
| ROE % | -36.6 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$42.50
+205.1%
Low: $38.00
High: $48.00
EPS Futuro
-$2.24
Ingresos Est.
2.3 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.58
$0.21 – $1.03
|
550 M | 2 |
| FY2029 |
-$0.94
-$1.68 – -$0.34
|
300 M | 2 |
| FY2028 |
-$1.93
-$3.38 – -$0.56
|
130 M | 4 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -146.72M
PEG of 0.89 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-36.61%
ROIC-27.94%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio9.95
Interest Coverage0.00
Valoración
P/E Ratio
-7.47
P/B Ratio2.54
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -162.45M |
| ROE | -36.61% | ROA | -30.45% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -146.72M |
| ROIC | -27.94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 9.95 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.47 | P/B Ratio | 2.54 |
| P/S Ratio | N/A | PEG Ratio | 0.89 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.21B | Enterprise Value | 1.17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -162.45M | -129.47M | -96.66M | -104.79M | -71.10M |
| EPS (Diluted) | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -178.70M | -142.26M | -104.96M | -106.99M | -71.49M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 533.43M | 450.98M | 276.95M | 215.65M | 295.95M |
| Total Liabilities | 54.87M | 42.02M | 23.05M | 18.10M | 11.38M |
| Shareholders' Equity | 478.56M | 408.96M | 253.90M | 197.55M | 284.57M |
| Total Debt | 1.19M | 1.43M | 2.42M | 2.57M | 3.29M |
| Cash & Equivalents | 48.30M | 139.48M | 68.54M | 23.70M | 13.81M |
| Current Assets | 515.45M | 438.47M | 266.51M | 208.90M | 290.69M |
| Current Liabilities | 51.80M | 41.76M | 21.62M | 16.55M | 9.02M |